BIOLOGICAL MODULATION OF HUMAN MELANOMA CELL INVASION
人类黑色素瘤细胞侵袭的生物调节
基本信息
- 批准号:3183872
- 负责人:
- 金额:$ 11.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-04-01 至 1990-03-31
- 项目状态:已结题
- 来源:
- 关键词:amnion antifibrinolytic agents athymic mouse basement membrane biological response modifiers cancer registry /resource electron microscopy fibrinolytic agents gel electrophoresis human tissue immunochemistry melanoma membrane activity metastasis monoclonal antibody neoplasm /cancer immunotherapy neoplasm /cancer invasiveness neoplastic cell plasminogen activator protein biosynthesis radiotracer tumor antigens
项目摘要
Metastatic melanoma has rapidly increased in incidence throughout the world
during the past decade. This insidious disease is generally undetected by
many patients until reaching incurable stages. Since metastatic melanoma
is currently considered to be incurable, research scientists have been
encouraged to explore new avenues of cancer treatment which may provide
hopeful perspectives in the handling of this invasive disease. Studies
aimed at understanding the biological progression of this invasive process
would undoubtedly be useful. The overall objective of our proposed
research is to further explore, in a reliable in vitro model which we have
developed, the study of human melanoma cell invasion that has been shown to
correlate with an in vivo animal model; specifically, the heterogeneous
invasive characteristics of high and low metastatic variants of melanoma
cells as they interact with an extracellular basement membrane (human
amnion) in the absence and presence of possible inhibitors and enhancers.
The specific aims for this three-year project are: (1) to examine the
intracellular and cell surface associated interactions of preinvasive,
invasive and postinvasive melanoma tumor cells interacting with basement
membranes in vitro; (2) to study the mechanism of tumor cell degradation by
identifying the specific type(s) of plasminogen activator (PA) and/or
proactivators and the physiological inhibitors of these activators produced
by high and low metastatic variants in the invasion model; also, to measure
the amount of PA activity associated with the cells when placed onto
membranes; (3) to study the magnitude of the inhibitory or stimulatory
effects of a specific biological response modifier, the exogenous addition
of fibrinolytic components or antibodies to these components on melanoma
tumor cells in vitro (particularly their degradative ability) as they
interact with an extracellular barrier; and (4) to explore the nature of
certain cell surface components that participate in tumor invasion. The
latter will include the use of monoclonal antibodies to highly metastatic
cell surface antigens (cell membrane glycoconjugates) of highly metastatic
cells which could possibly modulate tumor cell invasion.
转移性黑色素瘤在全世界的发病率迅速增加
在过去的十年里。 这种潜伏的疾病通常不会被发现,
许多患者直到达到无法治愈的阶段。 自从转移性黑色素瘤
目前被认为是无法治愈的,研究科学家们已经
鼓励探索癌症治疗的新途径,
在处理这种侵袭性疾病方面充满希望的前景。 研究
旨在了解这种侵入性过程的生物学进展,
毫无疑问是有用的。 我们建议的总体目标
研究是进一步探索,在一个可靠的体外模型,我们有
开发,人类黑色素瘤细胞侵袭的研究,已被证明,
与体内动物模型相关;具体而言,异质性
高转移和低转移性黑色素瘤的侵袭特征
细胞,因为它们与细胞外基底膜(人
羊膜)在不存在和存在可能的抑制剂和增强剂的情况下。
这项为期三年的计划的具体目标是:(1)研究
细胞内和细胞表面相关的相互作用,
侵袭性和侵袭后黑色素瘤肿瘤细胞与基底相互作用
膜的体外降解;(2)研究肿瘤细胞降解的机制,
鉴定纤溶酶原激活物(PA)的特定类型和/或
前活化剂和这些活化剂的生理抑制剂产生
通过侵袭模型中的高转移性和低转移性变体;此外,
与细胞相关的PA活性的量
(3)研究抑制性或刺激性的大小
特定生物反应调节剂的作用,外源性添加
纤维蛋白溶解成分或这些成分的抗体对黑色素瘤
体外肿瘤细胞(特别是它们的降解能力),因为它们
与细胞外屏障相互作用;(4)探索
某些参与肿瘤侵袭的细胞表面成分。 的
后者将包括使用单克隆抗体来高度转移
细胞表面抗原(细胞膜糖缀合物)
可能调节肿瘤细胞侵袭的细胞。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression.
苦马豆素和脱氧甘露尻霉素在体外抑制人黑色素瘤细胞侵袭,同时降低胶原酶 IV 表达。
- DOI:10.1097/00008390-199104000-00006
- 发表时间:1991
- 期刊:
- 影响因子:2.2
- 作者:Seftor,RE;Seftor,EA;Grimes,WJ;Liotta,LA;Stetler-Stevenson,WG;Welch,DR;Hendrix,MJ
- 通讯作者:Hendrix,MJ
A comparison of levels of intrinsic single strand breaks/alkali labile sites associated with human melanoma cell invasion.
与人类黑色素瘤细胞侵袭相关的内在单链断裂/碱不稳定位点水平的比较。
- DOI:10.1016/0304-3835(90)90009-m
- 发表时间:1990
- 期刊:
- 影响因子:9.7
- 作者:Meade-Tollin,LC;Pipes,BL;Anderson,SJ;Seftor,EA;Hendrix,MJ
- 通讯作者:Hendrix,MJ
Comparison of tumor cell invasion assays: human amnion versus reconstituted basement membrane barriers.
肿瘤细胞侵袭测定的比较:人羊膜与重建的基底膜屏障。
- DOI:
- 发表时间:1989
- 期刊:
- 影响因子:0
- 作者:Hendrix,MJ;Seftor,EA;Seftor,RE;Misiorowski,RL;Saba,PZ;Sundareshan,P;Welch,DR
- 通讯作者:Welch,DR
Artificial matrix barriers: a diffusion study utilizing dextrans and microspheres.
人工基质屏障:利用葡聚糖和微球的扩散研究。
- DOI:10.1002/ar.1092280104
- 发表时间:1990
- 期刊:
- 影响因子:0
- 作者:Persky,B;Hendrix,MJ
- 通讯作者:Hendrix,MJ
Growth, morphologic, and invasive characteristics of early and late passages of a human endometrial carcinoma cell line (RL95-2).
人子宫内膜癌细胞系 (RL95-2) 早期和晚期传代的生长、形态和侵袭特征。
- DOI:10.1007/bf02634139
- 发表时间:1992
- 期刊:
- 影响因子:0
- 作者:Sundareshan,P;Hendrix,MJ
- 通讯作者:Hendrix,MJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY J.C. HENDRIX其他文献
MARY J.C. HENDRIX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY J.C. HENDRIX', 18)}}的其他基金
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7847177 - 财政年份:2009
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7631169 - 财政年份:2007
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7913902 - 财政年份:2007
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7315494 - 财政年份:2007
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
8070504 - 财政年份:2007
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7460702 - 财政年份:2007
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7860642 - 财政年份:2007
- 资助金额:
$ 11.29万 - 项目类别:
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
微环境对干细胞可塑性和功能的表观遗传效应
- 批准号:
7080224 - 财政年份:2005
- 资助金额:
$ 11.29万 - 项目类别:
PROSTATIC VASCULOGENIC MIMICRY: A NEW METASTATIC PATHWAY
前列腺血管生成拟态:一种新的转移途径
- 批准号:
6474760 - 财政年份:2000
- 资助金额:
$ 11.29万 - 项目类别:
相似海外基金
Efficacy of Kunitz Domain 1 variants of TFPI-2 as novel antifibrinolytic agents
TFPI-2 Kunitz 结构域 1 变体作为新型抗纤维蛋白溶解剂的功效
- 批准号:
7589884 - 财政年份:2009
- 资助金额:
$ 11.29万 - 项目类别:
Efficacy of Kunitz Domain 1 variants of TFPI-2 as novel antifibrinolytic agents
TFPI-2 Kunitz 结构域 1 变体作为新型抗纤维蛋白溶解剂的功效
- 批准号:
7792289 - 财政年份:2009
- 资助金额:
$ 11.29万 - 项目类别:
Study on antifibrinolytic agents associated with central serous chorioretinopathy
中心性浆液性脉络膜视网膜病变相关抗纤溶药物的研究
- 批准号:
10671639 - 财政年份:1998
- 资助金额:
$ 11.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




